Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Interleukin-2 × Clear all

NCT00004050 2014-07-29

Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00040586 2007-01-22

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Phase 2 Completed

Prostatic Neoplasms